Global Oncology/Cancer Blockbuster Drugs Market Research Report 2019 - 2025
-
Product Code:
RP-ID-10082363 -
Published Date:
21 Oct 2022 -
Region:
Global
-
Pages:
115 -
Category:
Healthcare & Pharmaceuticals -
Publisher:
Pub-ID-24
Impact Analysis on the Growth of Market
Inflation and Looming Recession to Haunt Businesses:
In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.
....
The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.
With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.
Market Overview:
Translate Report
The global 27 cancer blockbuster drugs market size is set to surpass US$ 120 billion by 2025.
“Global Oncology/Cancer Blockbuster Drugs Market Research Report 2019 - 2025” presents an in-depth assessment of the global cancer blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up-to-date industry data on the actual market situation and future outlook for global cancer blockbuster drugs market. The report includes historical data from 2015 to 2018 and forecasts until 2025.
The report contains a granular analysis of the present industry situations, market demands, reveal facts on the market size, revenues and provides forecasts through 2025.The report provides clear insight into current and future developments of the global cancer blockbuster drugs market. The report explores detailed analysis of top 27 drugs market assessment globally from 2015 to 2018 and forecasts to 2025.
Key trends in terms of collaboration, merger & acquisition, partnerships, distribution and licensing agreement are analyzed with details. The report also explores detailed description of growth drivers and inhibitors of the global cancer blockbuster drugs market.
The report concludes with the profiles of major players in the global cancer blockbuster drugs market. The key market players are evaluated on various parameters such as business overview and recent development.
The Major Companies Dominating this Market for its Products, Services and Continuous Product Developments are:
1. Roche
2. Bristol-Myers Squibb
3. Pfizer
4. Eli Lilly and Company
5. Merck
6. Johnson & Johnson
7. AstraZeneca
8. Celgene
9. Novartis
10. Amgen
Top 27 Cancer Blockbuster Drugs Covered Under This Report Are:
1. Imbruvica
2. Revlimid
3. Pomalyst/Imnovid
4. Keytruda
5. Herceptin
6. Avastin
7. MabThera/Rituxan
8. Perjeta
9. Opdivo
10. Sprycel
11. Ibrance
12. Zytiga
13. Tagrisso
14. Darzalex
15. Xtandi
16. Jakafi/Jakavi
17. Yervoy
18. Alimta
19. Gleevec/Glivec
20. Velcade
21. Tasigna
22. Xgeva
23. Afinitor/Votubia
24. Neulasta
25. Exjade Jadenu
26. Sandostatin
27. Faslodex
The Latest Industry Data Included in this Report:
Global Top 27 Cancer Blockbuster Drugs Market Size & Analysis (2015 – 2025)
Global Top 27 Cancer Blockbuster Drugs Market Share & Y–o–Y Growth (%), 2015 – 2025
Global Top 27 Cancer Blockbuster Drugs Market Assessment & Opportunity, (2015 – 2025)
Major Deals (Mergers, Acquisitions, Key Agreements, Partnerships & Collaborations)
Key Market Drivers and Inhibitors of the Global Cancer Blockbuster Drugs Market
Major Companies Analysis
The Report Answers the Following Questions about the Global Cancer Blockbuster Drugs Market:
What is the size of the global top 27 cancer blockbuster drugs market during 2015 -2025?
What will be the revenue generated by each drug during the forecast period?
Which major drugs provides highest market share?
How are the overall market and major drugs growing?
What are the key drivers and inhibitors in the current market?
What will be the impact of drivers and inhibitors in the future?
How is the market predicted to develop in the future?
Who are the key players in this market space?
Geography Analysis:
The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:
- North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys & Opportunity Outlook
- Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook
.
